3
Metas de Enfermería

Metas de Enfermería

MAYO 2014 N° 4 Volumen 17

The efficacy of essential fatty acids vs. hyperoxygenated fatty acids for the prevention of pressure ulcers in patients with long-term hospitalization

Section: Cover story

How to quote

García Alcara F, Salmerón Cifuentes S, Martínez Nieto MJ, Tejada Cifuentes F. Eficacia de los ácidos grasos esenciales frente a los ácidos grasos hiperoxigenados en la prevención de aparición de úlceras por presión en pacientes institucionalizados. Metas Enferm may 2014; 17(4): 19-25.

Authors

1Francisco García Alcaraz, 2Soledad Salmerón Cifuentes, 3María José Martínez Nieto, 4Francisco Tejada Cifuentes

Position

1Máster Oficial en Ciencias de Enfermería. Profesor de Enfermería Comunitaria de la Facultad de Enfermería de Albacete (UCLM). 2Coordinadora de Enfermería de la Residencia de Mayores Alcabala (Albacete).3Enfermera asistencial. Residencia de Mayores Alcabala (Albacete).4Doctor en Farmacia. Farmacéutico de Atención Primaria. Gerencia de Atención Integrada de Albacete (SESCAM).

Contact address

Francisco García Alcaraz. C/ Oro, 3-2º Centro. 02002 Albacete.

Abstract

Objective: to determine the efficacy of essential fatty acids (EFAs)) vs. hyperoxygenated fatty acids (HOFAs) for the prevention of Grade 1 pressure ulcers (PUs) in the hospitalized geriatric population of patients with risk of developing PUs.
Method: a randomized clinical trial conducted on a population with long-term hospitalization. Patients were randomly assigned to the experimental arm (33 patients who received EFAs), and the control arm (32 patients who received HOFA). Both products were applied topically every 12 hours. The incidence of Grade 1 PUs was measured at 7, 14, 21 and 28 days. The source of information was patients’ clinical records. The risk of developing PUs was assessed through the Norton Scale. Prevention measures conducted were validated. For bivariate analysis, comparison tests of mean values were conducted (Student’s t test for independent samples), as well as of percentages (Square Ji).
Results: out of the 65 patients included in the study, 32 were in the HOFA arm and 33 in the EFA arm. The maximum incidence of Grade 1 PUs per week was 12.9% in the HOFA arm and 12.5% in the EFA arm. No significant differences were found between both treatment arms.
Conclusions: the administration of EFA and HOFA represents equally effective measures for preventing the development of PUs.

Keywords:

Essential fatty acids; hyperoxygenated fatty acids: prevention; pressure ulcers; population with long-term hospitalization; researchrandomized clinical trial

Versión en Español

Título:

Eficacia de los ácidos grasos esenciales frente a los ácidos grasos hiperoxigenados en la prevención de aparición de úlceras por presión en pacientes institucionalizados

Artículo completo no disponible en este idioma / Full article is not available in this language

Bibliography

  1. Soldevilla JJ, Torra JE, Verdú J, López P. 3er Estudio nacional de prevalencia de úlceras por presión en España, 2009. Epidemiología y variables definitorias de las lesiones y pacientes. Gerokomos 2011; 22(2):77-90.
  2. White-Chu EF, Flock P, Struck B, Aronson L. Pressure ulcers in long-term care. Clin Geriatr Med 2011; 27:241-258.
  3. Reddy M, Gill SS, Kalkar SR, Wu W, Anderson PJ, Rochon PA. Treatment of Pressure Ulcers: A Systematic Review. JAMA 2008; 300(22):2647-62.
  4. Informe Plan de Calidad para el Sistema Nacional de Salud. Balance de actividades y acciones previstas. Madrid: Ministerio de Sanidad y Política Social; 2009. [En línea] [fecha de acceso: 20 de marzo de 2014]. URL disponible en: http://www.msssi.gob.es/organizacion/sns/planCalidadSNS/informe0610/InformePlanCalidad_ESP.pdf
  5. Bazin S, Blanch M, Hampton J, Henderson H, Morris J, O’Brien M, et al.The management of pressure ulcers in primary and secondary care. A Clinical Practice Guideline. London: Royal College of Nursing and National Institute for Health and Clinical Excellence; 2005. [En línea] [fecha de acceso: 20 de marzo de 2014]. URL disponible en: http://www.nice.org.uk/nicemedia/pdf/CG029fullguideline.pdf
  6. Chou R, Dana T, Bougatsos C, Blazina I, Starmer A, Reitel K, Buckley D. Pressure ulcer risk assessment and prevention: comparative effectiveness. Rockville: Agency for Healthcare Research and Quality (AHRQ) 2013; 12(13). [En línea] [fecha de acceso: 20 de marzo de 2014]. URL disponible en: http://www.effectivehealthcare.ahrq.gov/ehc/products/309/1489/pressure-ulcer-prevention-report-130528.pdf
  7. Segovia T, Bermejo M, Molina Silva R, Rueda J, Bou JE. Skin care and pressure ulcer. Hyperoxygenated fatty acids in the prevention of pressure ulcers and treatment of stage I lesions. Rev Enferm 2001; 24(9):18-22.
  8. Candela Zamora MD, Martín Gómez MA, Solas Gómez B, Fernández Pérez C, Martín González M, Manzanedo Basilio L, et al. Comparative study of the effectiveness two of hyperoxygenated fatty acids in the treatment of grade I ulcers in geriatric hospitalized patients. Enferm Clin 2010; 20(1):10-16.
  9. Torra i Bou JE, Segovia T, Verdú J, Nolasco A, Rueda J, Arboix i Perejamo M. The effectiveness of a hyperoxygenated fatty acid compound in preventing pressure ulcers. J Wound Care 2005; 14(3):117-121.
  10. Segovia T, Javares T, Barahona M, Verdú J. Cuidados en piel perilesional o con riesgo de lesión: resultados de la aplicación de ácidos grasos hiperoxigenados con aloe barbadensis y mimosa tenuiflora (Mepentol Leche). Revista ROL Enferm 2007; 30(10):683-688.
  11.  Jude EB, Tentolouris N, Appleton I, Anderson S, Boulton AJM. Role of neuropathy and plasma nitric oxide in recurrent neuropathic and neurosichemic diabetic foot ulcers. J Wound Rep Reg 2001; 9(5):353-359.
  12. Prottey C, Hartop PJ, Press M. Correction of the cutaneous manifestation of essential fatty acid in man by application of sun flower-seed oil to skin. J Invest Dermatol 1975; 64:228-234.
  13.  Baker J. Essential oils: a complimentary therapy in wound management. J Wound Care 1998; 7:355-360.
  14. Moreno Pina JP, Richart Martínez M, Guirao Goris JA, Duarte Climents G. Análisis de las escalas de valoración del riesgo de desarrollar una úlcera por presión. Enferm Clin 2007; 17(4):189-197.
  15. Hermosilla T. Efectividad de las intervenciones para la prevención de las úlceras por presión: evidencias e incertidumbres. Biblioteca Cochrane Plus; 2014.
  16. Anguera L, Colodrero E, García N, Mateo E, Roca A, Velasco MC. La educación como pieza clave en la prevención y buena evolución de las úlceras por presión. Enferm Intensiva 2009; 20(1):19-26.
  17. Pham B, Stern A, Chen W, Sander B, John-Baptiste A, Thein HH, et al. Preventing pressure ulcers in long-term care. A cost-effectiveness analysis. Arch Intern Med 2011; 171(20):1839-47.
  18. Rodríguez M, Vallejo JM. La gestión de úlceras por presión en residencias de mayores. Obstáculos y facilitadores. Gerokomos 2010; 21(3):108-113.
  19. Black J, Clark M, Dealey C, Brindle CT, Alves P, Santamaria N, et al. Dressings as an adjunct to pressure ulcer prevention: consensus panel recommendations. International Wound Journal 2014;1-5.
  20. Lupiáñez Pérez I, Morilla Herrera JC, Ginel Mendoza L, Martín Santos FJ, Navarro Moya FJ, Sepúlveda Guerra RP, et al. Effectiveness of olive oil for the prevention of pressure ulcers caused in immobilized patients within the scope of primary health care: study protocol for a randomized controlled trial. Bio Med Central 2013. [En línea] [fecha de acceso: 20 de marzo de 2014]. URL disponible en: http://www.bibliotecacochrane.com/BCPGetDocument.asp?SessionID=%202040594&DocumentID=GCS30-9